Implementation of an Environmental Cleaning Protocol in Hospital Critical Areas Using a UV-C Disinfection Robot.

high-touch surfaces hospital environmental cleaning and disinfection ultraviolet C light-emitting device

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
28 02 2023
Historique:
received: 08 02 2023
revised: 24 02 2023
accepted: 25 02 2023
entrez: 11 3 2023
pubmed: 12 3 2023
medline: 15 3 2023
Statut: epublish

Résumé

Improving the cleaning and disinfection of high-touch surfaces is one of the core components of reducing healthcare-associated infections. The effectiveness of an enhanced protocol applying UV-C irradiation for terminal room disinfection between two successive patients was evaluated. Twenty high-touch surfaces in different critical areas were sampled according to ISO 14698-1, both immediately pre- and post-cleaning and disinfection standard operating protocol (SOP) and after UV-C disinfection (160 sampling sites in each condition, 480 in total). Dosimeters were applied at the sites to assess the dose emitted. A total of 64.3% (103/160) of the sampling sites tested after SOP were positive, whereas only 17.5% (28/160) were positive after UV-C. According to the national hygienic standards for health-care setting, 9.3% (15/160) resulted in being non-compliant after SOP and only 1.2% (2/160) were non-compliant after UV-C disinfection. Operation theaters was the setting that resulted in being less compliant with the standard limit (≤15 colony-forming unit/24 cm

Identifiants

pubmed: 36901293
pii: ijerph20054284
doi: 10.3390/ijerph20054284
pmc: PMC10001687
pii:
doi:

Substances chimiques

Xenon 3H3U766W84

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Am J Infect Control. 2019 Apr;47(4):400-405.e1
pubmed: 30554878
Lancet. 2017 Feb 25;389(10071):805-814
pubmed: 28104287
Infect Control Hosp Epidemiol. 2019 Feb;40(2):158-163
pubmed: 30698135
Science. 1935 Sep 20;82(2125):280-1
pubmed: 17792965
J Hosp Infect. 2018 Oct;100(2):236-241
pubmed: 29772262
PLoS One. 2021 Jul 26;16(7):e0241734
pubmed: 34310599
PeerJ. 2020 Oct 13;8:e10196
pubmed: 33083158
J Hosp Infect. 2022 Oct;128:19-25
pubmed: 35820555
Int J Environ Res Public Health. 2019 Sep 24;16(19):
pubmed: 31554297
Curr Infect Dis Rep. 2015 Sep;17(9):498
pubmed: 26252970
Infect Control Hosp Epidemiol. 2017 Sep;38(9):1116-1117
pubmed: 28669367
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
J Hosp Infect. 2015 Sep;91(1):35-44
pubmed: 26187533
Lancet Infect Dis. 2008 Feb;8(2):101-13
pubmed: 17974481
Am J Infect Control. 2010 Jun;38(5 Suppl 1):S25-33
pubmed: 20569853
BMC Infect Dis. 2021 Jun 22;21(1):594
pubmed: 34157967
Am J Infect Control. 2016 Apr 1;44(4):416-20
pubmed: 26684367
Infect Control Hosp Epidemiol. 2008 Nov;29(11):1035-41
pubmed: 18851687
J Microbiol Immunol Infect. 2019 Jun;52(3):487-493
pubmed: 28951015
Infect Control Hosp Epidemiol. 2022 Feb;43(2):232-237
pubmed: 33685546
J Hosp Infect. 2015 Apr;89(4):287-95
pubmed: 25638358
Am J Infect Control. 2010 Jun;38(5 Suppl 1):S41-50
pubmed: 20569855
Infect Dis Clin North Am. 2016 Sep;30(3):609-37
pubmed: 27515140
J Hosp Infect. 2012 Jan;80(1):52-5
pubmed: 21899921
Ont Health Technol Assess Ser. 2018 Feb 07;18(1):1-73
pubmed: 29487629
J Hosp Infect. 2004 Jan;56(1):10-5
pubmed: 14706265
Antimicrob Resist Infect Control. 2022 Feb 19;11(1):38
pubmed: 35183259
Infect Control Hosp Epidemiol. 2001 Apr;22(4):248-57
pubmed: 11379716
Am J Infect Control. 2013 May;41(5 Suppl):S6-11
pubmed: 23622751
J Hosp Infect. 2015 Jan;89(1):16-27
pubmed: 25447198
BMC Infect Dis. 2010 Jul 08;10:197
pubmed: 20615229
Infect Control Hosp Epidemiol. 2016 Mar;37(3):340-2
pubmed: 26821275
Clin Microbiol Rev. 2014 Oct;27(4):665-90
pubmed: 25278571
Front Robot AI. 2021 Jan 06;7:590306
pubmed: 33501347
Soc Sci Med. 2017 Feb;174:64-69
pubmed: 28012431

Auteurs

Beatrice Casini (B)

Department of Translational Research and the New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.

Benedetta Tuvo (B)

Department of Translational Research and the New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.

Michela Scarpaci (M)

Department of Translational Research and the New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.

Michele Totaro (M)

Department of Translational Research and the New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.

Federica Badalucco (F)

Department of Translational Research and the New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.

Silvia Briani (S)

Hospital Management, University Hospital of Pisa, 56126 Pisa, Italy.

Grazia Luchini (G)

Hospital Management, University Hospital of Pisa, 56126 Pisa, Italy.

Anna Laura Costa (AL)

Department of Translational Research and the New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.

Angelo Baggiani (A)

Department of Translational Research and the New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH